Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $27.0000 (-1.82%) ($24.8000 - $29.4000) on Tue. Nov. 14, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 11.71% (three month average) | RSI | 58 | Latest Price | $27.0000(-1.82%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 6% a day on average for past five trading days. | Weekly Trend | CAPR advances 2.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) EWG(8%) SKYY(8%) TBT(8%) XLF(8%) ARKK(7%) | Factors Impacting CAPR price | CAPR will decline at least -5.855% in a week (0% probabilities). TLT(-8%) GLD(-8%) GDX(-8%) SLV(-6%) SIL(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -5.855% (StdDev 11.71%) | Hourly BBV | 0 () | Intraday Trend | -6.6% | | | |
|
5 Day Moving Average | $24.9(8.43%) | 10 Day Moving Average | $23.48(14.99%) | 20 Day Moving Average | $23.52(14.8%) | To recent high | -21.7% | To recent low | 178.4% | Market Cap | $532m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |